Sands Capital Ventures Discovery Fund III L.P. 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-12 9:08 pm Purchase | 2021-07-06 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Sands Capital Ventures Discovery Fund III L.P. | 3,417,075 8.840% | 3,417,075 (New Position) | Filing |